One of these companies, 10X Genomics, which gives users hardware and software to determine the functionality of different genetic code, has already proven how lucrative this early market can be.

GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic applications.

Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering - $55 million Series A financing will advance the company’s robust preclinical ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One ...